295. Stage 4 De Novo with Brain Mets Virginia Rodriguez First Line Treatment on Verzenio

Love the podcast? Send us a text!In this episode of Breast Cancer Conversations, Laura speaks with Virginia Rodriguez, who was diagnosed with stage 4 de novo metastatic breast cancer after experiencing progressive weakness, digestive issues, dehydration, and a dramatic decline in her ability to walk and function.Virginia shares what it was like to go from hiking the Camino de Santiago to struggling to climb the stairs in her own home, the emotional experience of finally receiving a diagnosis after months of unanswered symptoms, and how her care team identified breast cancer that had spread to multiple areas, including her brain, spine, liver, spleen, and bones.Virginia was placed on Verzenio, also known as abemaciclib, as part of her first line of treatment. Verzenio is an oral CDK4/6 inhibitor used in certain HR-positive, HER2-negative advanced or metastatic breast cancers, including in combination with endocrine therapy depending on a person’s treatment history and clinical situationSupport the showListener FeedbackIf this episode resonated with you, we invite you to leave a review on Apple Podcasts or Spotify.You can also click the link in the show notes that says "Love this episode? Send us a text" to share feedback.Messages are completely anonymous.If you would like us to follow up directly, please include your email address in your message so we can respond.Latest News: Join our Mailing List - New content drops every Monday! Discover FREE programs, support groups, and resources from SurvivingBReastCancer.org! Become a Breast Cancer Conversations+ Member! Sign Up Now. Enjoying our content? Please consider supporting our work.